期刊文献+

羟基喜树碱微粉的制备及抗肿瘤活性 被引量:2

Preparation and Antitumor Activities of Micronized Hydroxycamptothecin
原文传递
导出
摘要 目的制备羟基喜树碱微粉(nHCPT)并考察其毒性和抗肿瘤活性。方法本实验采用超临界流体抗溶剂法制备nH-CPT,扫描电子显微镜(SEM)观察形态、原子力显微镜(AFM)检测其粒径。红外光谱(FTIR)和高效液相色谱确认nHCPT化学性质。气相色谱法测定nHCPT中残留DMSO含量。以HCPT和拓朴替原(TPT)为阳性对照,四甲基偶氮唑蓝(MTT)法检测nHCPT对PC-3、MCF-7和HCT-8细胞的生长抑制作用。显微操作系统观察HCT-8细胞对于nHCPT吸收。采用S180实体瘤模型,考察了nHCPT的抗肿瘤活性和对器官的毒性。结果超临界处理后的nHCPT以无定型形态存在,粒径为(150±40)nm,形态为不规则球状结构,化学性质没有改变。nHCPT中残留DMSO含量符合ICH要求。样品在4℃、避光干燥条件下储存一个月后性质稳定。nHCPT对3种细胞株的抑制率略优于HCPT和TPT,nHCPT的细胞膜渗透能力较HCPT明显增强。nHCPT的体内抑瘤活性较HCPT明显提高,与TPT抑瘤活性相近,且对器官毒副作用明显低于TPT和HCPT。结论 nHCPT具有独特的优越性,可以作为进一步新制剂开发的原料药。 OBJECTIVE To prepare micronized hydroxycamptothecin(nHCPT),and to investigate the antitumor activities and toxicity of nHCPT.METHODS Micronized hydroxycamptothecin was prepared using Supercritical Anti-Solvent Processis method(SAS).The morphology and the particle size of nHCPT were detected by SEM and AFM,respectively.The chemical properties of nHCPT were confirmed by FTIR and HPLC.The content of the residual DMSO was determined by GC analysis.The cytotoxicity on nHCPT on PC-3,MCF-7 and HCT-8 was evaluated by MTT method using HCPT and TPT as positive control,and the nHCPT uptakes by cultured HCT-8 cells were investigated by Micromanipulator System.The inhibition effect against tumors and the toxicity on organs of nHCPT were determined in sarcoma-180(S-180) bearing mice.RESULTS The particle size of nHCPT was(150±40) nm,and the morphology was irregularly spherical.nHCPT showed amorphous form,and the chemical properties was not changed.The residual DMSO content in nHCPT was less than the ICH limit.The samples were stable during storage at 4 ℃ and drying condition for a month in the dark.The inhibition rate of nHCPT was higher than HCPT and TPT on three kinds of tumor cells,and the ability of penetration into cell membrane was improved obviously compared with HCPT.nHCPT also exhibited superior antitumor activities compared with HCPT,which was similar to TPT.However,nHCPT had less toxicity than TPT and HCPT.CONCLUSION nHCPT had potential to become the drug material of new drug formulations due to it′s special characterization.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第23期1831-1836,共6页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30600052) 2006新世纪优秀人才项目(NCET-06-0329) 黑龙江省留学基金 国家林业局重点项目(2007-12) 黑龙江省青年科学基金(QC08C30) 黑龙江省和哈尔滨市人才基金(2010RFLXS013) 东北林业大学人才项目(DL09DAQ02)
关键词 羟基喜树碱微粉 超临界抗溶剂法 抑瘤活性 毒性 拓朴替原 micronized hydroxycamptothecin supercritical anti-solvent processes method antitumor activities toxicity topotecan
  • 相关文献

参考文献9

二级参考文献69

共引文献106

同被引文献50

  • 1闫石,邹梅娟,徐彩红,万丽萍,王翔宇,程刚.乳化溶剂扩散法制备叶黄素缓释微球[J].中国药剂学杂志(网络版),2009(5):391-397. 被引量:3
  • 2齐菲.羟基喜树碱剂型的研究进展[J].中国药业,2005,14(9):93-94. 被引量:8
  • 3张炎强,李湘洲,周雯雯.姜黄色素的提取与检测技术研究进展[J].经济林研究,2006,24(2):74-77. 被引量:22
  • 4童培云,席晓丽,蒋亚宝,翟立力,聂祚仁.冷冻干燥技术制备超微粉体的研究进展[J].粉末冶金工业,2007,17(2):45-50. 被引量:10
  • 5陈秀珍.注射羟基喜树碱冻干粉针剂的制备方法[P].中国:02138930.6.2002-08-15.
  • 6KONO K, OZAWA T, YOSHIDA T, et al. Highly temperature - sensitive liposomes based on a thermosensitive blck copolymer for tumor - specific chemotherapy [ J ]. Biomaterials, 2010, 31 (27) :7096 -7105.
  • 7FERRANDINA G, CORRADO G, LICAMELI A, et al. Pegylat- ed liposomal doxorubicin in the management of ovarian cancer [J]. Ther Clin Risk Manag, 2010, 6:463-483.
  • 8易以木,陈秀珍.羟基喜树碱葡聚糖纳米粒的制备方法[P].中幽:01138252.X,200l-12-06.
  • 9易以木,杨唐玉,吴汉强,等.羟基喜树碱聚乳酸纳米粒的制备方法[P].中国:01133700.1,2001-11-22.
  • 10汪雷.银杏提取物微粉化制备工艺研究[D].哈尔滨:东北林业大学,2012.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部